CUE
Cue Biopharma, Inc. · Healthcare
VP, Prin. Accounting Officer Michael Vincent Meluzio sold $169K of Cue Biopharma, Inc.
Sold$169,324
$30.09Price
5,628Shares
−10%Stake
What CUE did after the filing
- The stock from Tue, Aug 18 open, $27.39
- −5.5%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Sep 30 close.
Traded Thu, Aug 13. Filed Mon, Aug 17, 6:19 PM ET, after the close. Returns use the Aug 18 open and the Sep 30 close. Not investment advice.